Michal Galek-Aldridge | Health Sciences | Best Scholar Award

Published on by Research Awards

Mr. Michal Galek-Aldridge | Health Sciences | Best Scholar Award

University Medical Center Utrecht | Netherland

Michał Gałek-Aldridge is a multilingual medical researcher and physician with a strong interdisciplinary background bridging molecular science, engineering, and regenerative medicine. Born on September 18, 1993, in Tucson, Arizona, he holds Polish nationality and is fluent in English, Dutch, Polish, and Russian, with advanced proficiency in French and beginner-level Portuguese. Michał’s academic journey spans multiple international institutions, including The British School of Warsaw, the Anglo-American School in Moscow, and the International School of Amsterdam, culminating in an International Baccalaureate (IB) bilingual diploma in 2011. He pursued a Bachelor of Science in Molecular Science and Technology at Delft University of Technology and Leiden University, completing his thesis on “The loading of chemotherapeutics in polymersome carriers” at the Reactor Institute Delft. During this period, Michał received an Erasmus Mundus scholarship to study at Chalmers University in Sweden, where he expanded his expertise in nuclear chemistry, project management, waste management, and ecology. Driven by a passion for medicine, he subsequently earned both a Bachelor and Master of Science in Medicine at the University of Amsterdam, with clinical experience in orthopedic surgery at the UMC Amsterdam. Since 2021, Michał has been a PhD candidate at the University Medical Center Utrecht, focusing on the translation of regenerative surgical shoulder implants into clinical practice. His research integrates advanced therapies, 3D-printed medical devices, and regenerative medicine, while also addressing regulatory compliance, intellectual property assessment, and GMP evaluation for ATMP production. He actively supervises students at the 3D Lab, contributing to both academic and translational research. His work is supported by prominent supervisors including Prof. Michel van den Bekerom, Dr. Arthur van Noort, Dr. Bart van der Wal, and Prof. Jos Malda. Michał has contributed extensively to the scientific literature, publishing as first author on innovative orthopedic treatments and as co-author in high-impact journals, including The Lancet Respiratory Medicine, Journal of Shoulder and Elbow Surgery, and JSES Reviews, Reports & Techniques. His research has spanned topics from patient-specific bone regenerative implants and congenital hip dislocation management to COVID-19 respiratory subphenotypes and ventilation strategies. Michał’s professional development is complemented by diverse certifications and conferences, including Medical Device Regulation (EU MDR 2018), ISO 13485, 3D printing in hospitals, and arthroscopy and arthroplasty courses. Outside of his professional endeavors, he maintains an active lifestyle through kickboxing, Muay Thai, skiing, kite surfing, and cooking. His combination of scientific rigor, clinical expertise, and entrepreneurial initiative positions him as a rising leader in regenerative medicine and medical innovation.

Profile: Scopus

Featured Publications

van Spanning, S. H., van Iersel, T. P., Verweij, L. P. E., van Noort, A., Floor, S., Galek-Aldridge, M., van den Borne, M. P. J., Kleinlugtenbelt, Y. V., van den Bekerom, M. P. J., & van Deurzen, D. F. P. (2025). Lower education level is associated with failure to return to sport whereas bony Bankart lesions predict successful return to preinjury sport level after open Latarjet procedure. Arthroscopy: The Journal of Arthroscopic & Related Surgery. Advance online publication.

 

Yogesh Subramanian | Health Sciences | Best Academic Researcher Award

Published on by Research Awards

Dr. Yogesh Subramanian | Health Sciences | Best Academic Researcher Award

Madras Medical College | India 

Dr. Yogesh Subramanian, M.D., is an accomplished Senior Assistant Professor and Medical Teacher at the Institute of Internal Medicine, Madras Medical College and Rajiv Gandhi Government General Hospital (RGGGH), Chennai. With over a decade of distinguished service in clinical medicine, teaching, and research, Dr. Yogesh has made exceptional contributions to the advancement of internal medicine, medical education, and clinical innovation. He holds an M.D. in General Medicine from Stanley Medical College and an M.B.B.S. from PSG Institute of Medical Sciences, Coimbatore. His career reflects an enduring commitment to excellence in patient care, evidence-based learning, and academic leadership. Dr. Yogesh has completed more than 20 research projects and published over 34 indexed papers across reputed international databases such as PubMed, Google Scholar, and ResearchGate. He is currently pursuing 10 ongoing research projects, including ICMR-funded and international collaborative studies. His multidisciplinary research focuses on Internal Medicine, Endocrinology, Hematology, Infectious Diseases, Critical Care, and Medical Education. Notably, his innovative “M-Health App for T2DM Patients,” currently under patent processing, demonstrates his vision of integrating technology with healthcare delivery to improve chronic disease management. A passionate academician and faculty trainer, Dr. Yogesh has been actively involved in the implementation of Competency-Based Medical Education (CBME) and faculty development under the National Medical Commission (NMC) Nodal Centre. His research on new learning methodologies and competency-based teaching, presented at prestigious global platforms such as the Ottawa 2024 Conference in Australia and the AIIMS Kalyani Medical Education Meet in 2023, has significantly influenced modern medical pedagogy. His efforts have earned national and institutional recognition, including the National Teachers Day Award 2024, Best Researcher Award 2024, and a Gold Medal at APICON 2024. A dedicated member of professional organizations including the Indian Medical Association, Association of Physicians of India, NFED, International Society for Renal Research, and TNGDA, Dr. Yogesh exemplifies professional excellence and community engagement. His scholarly impact is further reflected by his Google Scholar h-index of 4, showcasing the quality and reach of his research contributions.

Profile: Google Scholar

Featured Publications

Sud, R., Agarwal, N., Aishwarya, V., Aggarwal, A., Kalawatia, M., Sangoi, R., … (2023). A case series of dengue myocarditis: A complication observed in dengue patients. Cureus, 15(11).

Nallathambi, N., & Chinnadurai, A. (2024). Carboplatin-induced hematuria with obstructive acute kidney injury. Cureus, 16(4).

Kothari, R., Johny, M. P., D., Mistry, D., Irfana, M., Yogesh, S., & Vemparala, S. S. (2024). Grip to health: Unlocking the clinical potential of isometric hand grip strength—A narrative review. Journal of Pharmacy and Bioallied Sciences, 16(Suppl 4), S3102–S3104.

Prashanth, A., Kothari, R., Yogesh, S., Mittal, G., Gheewala, S., Bokariya, P., … (2023). Examining body fat percentage, galvanic skin response, and muscle grip strength in female hypothyroid patients. Cureus, 15(7).

Mittal, G., Prashanth, A., Dhali, A., Prasad, R., Yogesh, S., Nurani, K. M., … (2025). Plant extracts with antioxidant and hepatoprotective benefits for liver health: A bibliometric analysis of drug delivery systems. World Journal of Gastroenterology, 31(18), 105836.

Chandrashekar, N. G., Murali, N. V. I., Mohammed, A. I., Hemachandran, D., … (2024). Comprehensive clinical profile and hemodialysis outcomes in patients attending a tertiary care hospital. Cureus, 16(8).

Yogesh, S., Venkatesan, S., Jayaraj, A. T., Karthigeyan, T. S., Siva Prasath, S., … (2024). Understanding the complexity of hyperglycemic emergencies: Exploring the influence of the type and duration of diabetes mellitus and its impact on mortality. Cureus, 16(4).

Yogesh, S., Nallathambi, N., Seshadri, H., Gautham, R., Naidu, S. P., Navvin, S., … (2024). Assessing the effect of the anti-tuberculosis drug rifampicin on known hypertensive patients with tuberculosis in a tertiary care center. Cureus, 16(4).

Hongxia Jiang | Health Sciences | Best Researcher Award

Published on by Research Awards

Dr. Hongxia Jiang | Health Sciences | Best Researcher Award 

Dr. Hongxia Jiang, Zhongnan hospital of Wuhan University, China

Dr. Hongxia Jiang is a distinguished medical professional at Zhongnan Hospital of Wuhan University, China, renowned for her expertise in clinical research and patient-centered care. With a strong background in health sciences and a commitment to advancing medical innovation, Dr. Jiang has contributed significantly to evidence-based medical practices through both her clinical work and research endeavors. Her dedication to improving healthcare outcomes and her role in advancing translational medicine make her a respected figure in the Chinese medical community and beyond.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Hongxia Jiang began her academic journey with a passion for science and a dedication to improving human health. She pursued her medical education at one of China’s esteemed institutions, demonstrating excellence in both academic knowledge and clinical training. Her early focus was on internal medicine and translational healthcare—fields where she showed an affinity for integrating diagnostics, treatment, and research.

From her undergraduate years, Dr. Jiang stood out for her analytical mindset and problem-solving ability, frequently contributing to peer-reviewed student research journals and clinical practice groups. Her academic mentors recognized her early potential, encouraging her to pursue a path that blends clinical service with cutting-edge research—a combination that has remained at the heart of her career.

🩺 Professional Endeavors

Currently serving at Zhongnan Hospital of Wuhan University, a top-tier teaching and research hospital in China, Dr. Jiang plays a vital role in both clinical operations and medical research. Her clinical acumen, especially in managing complex cases, has earned her trust among patients and peers alike.

As a dedicated physician, she specializes in comprehensive patient care, focusing on diagnostics, preventive medicine, and therapeutic innovation. She is also actively involved in mentoring younger medical staff, shaping the next generation of clinicians with a strong emphasis on ethical practice and evidence-based treatment.

Moreover, Dr. Jiang has been a key contributor to several interdisciplinary medical initiatives at the hospital, particularly in collaboration with departments like oncology, infectious disease, and intensive care. These efforts have not only improved patient outcomes but also paved the way for protocol innovations adopted at other institutions.

🔬 Contributions and Research Focus

Dr. Jiang’s research spans multiple areas within clinical and translational medicine, with special interests in:

  • Molecular diagnostics and biomarker discovery

  • Infectious disease management and public health surveillance

  • Cancer therapy optimization and drug resistance mechanisms

  • Clinical trials focused on novel treatment approaches

She has published in respected national and international medical journals and has presented her findings at conferences and medical symposia across Asia and Europe. Her research work bridges the gap between laboratory science and bedside application, ensuring that scientific innovation directly benefits patients.

Dr. Jiang is also known for pioneering collaborative projects, often engaging with multi-disciplinary teams across China and abroad. This has led to co-authored publications and joint research funding awards that support ongoing medical advancements.

🏅 Accolades and Recognition

Dr. Hongxia Jiang has received numerous accolades that recognize both her clinical excellence and research contributions. These include:

  • Outstanding Physician Award by Zhongnan Hospital

  • Best Paper Presentation at a national medical research forum

  • Research Grant Recipient for translational medicine from a provincial science foundation

  • Repeated acknowledgments from patients and hospital leadership for her empathy, innovation, and leadership

Her consistent contributions have made her a role model in the Chinese healthcare system, and she is frequently invited as a guest lecturer and expert panelist on public health and hospital quality initiatives.

🌍 Impact and Influence

Dr. Jiang’s work has had a profound impact not only on her institution but also on regional health policies and treatment protocols. Her research on infection control and clinical interventions during public health crises (including during the COVID-19 pandemic) has been cited in shaping response strategies in Wuhan and neighboring provinces.

She is a respected collaborator and continues to influence public health discourse, advocating for data-driven care, equitable access to healthcare, and patient safety.

🌟 Legacy and Future Contributions

Looking ahead, Dr. Jiang is committed to advancing global health through collaborative science, with aspirations to lead international trials and establish regional centers of research excellence. Her vision includes:

  • Creating more patient-centered care models

  • Integrating AI and machine learning into diagnostics

  • Championing women in medicine and research leadership

Her legacy is being built not just through research papers or clinical breakthroughs but through the lives she transforms and the systems she helps innovate for future generations.

📝Publication Top Notes

A cross-sectional study on nutritional risk and frailty in elderly patients with chronic obstructive pulmonary disease

Author: L., Liu, Lingfang, Y., Fang, Yanhong, J., Dong, Jia, … Z., Cheng, Zhenshun, C., Wu, Changrong

Journal: Medical Journal of Wuhan University

Year: 2024

 

 

Guoying Yu | Environmental Health | Best Researcher Award | 13389

Published on by Research Awards

Prof. Guoying Yu | Environmental Health | Best Researcher Award 

Prof. Guoying Yu, Henan Normal University, China

Professor Guoying Yu is a distinguished biomedical scientist and professor at the College of Life Sciences, Henan Normal University, China. With a Ph.D. in Ecology from the Chinese Academy of Sciences and postdoctoral experience at Yale and the University of Pittsburgh, Dr. Yu has made significant contributions to lung biology, focusing on acute lung injury, pulmonary fibrosis, and thyroid hormone-based therapies. His innovative research has been published in top-tier journals like Nature Communications and Advanced Science, and he has secured major national and provincial research grants. A leader in translational medicine, Dr. Yu is widely respected for his impactful work, international collaborations, and dedication to advancing global health through scientific innovation.

Profile

Scopus

🏫 Early Academic Pursuits

Professor Guoying Yu’s journey into science began with a deep-rooted passion for biology and ecology. Born in China, he pursued his undergraduate studies at Henan Normal University, graduating in 1985 with a strong academic foundation in life sciences. Determined to explore ecological systems at a deeper level, he obtained his Master’s degree from Yunnan University in 1989. His unwavering commitment to academic excellence propelled him toward doctoral studies, and he earned his Ph.D. in Ecology in 1995 from the Chinese Academy of Sciences, China’s leading research institution.

Dr. Yu’s Ph.D. work laid a critical foundation in interdisciplinary environmental biology, a focus that later expanded into biomedical research. His academic brilliance and research discipline were evident from these formative years, building a strong base for his future endeavors.

👨‍🔬 Professional Endeavors

After receiving his Ph.D., Dr. Yu broadened his horizons through prestigious postdoctoral fellowships at the University of Pittsburgh (USA) and the Chinese Academy of Sciences. His research during this period focused on biomedical applications of molecular ecology, marking his transition into translational and clinical research.

Over the years, he has held esteemed research and academic positions at globally recognized institutions including Yale University, University of Pittsburgh, and Chinese academic universities. Currently, Dr. Yu is a Professor at the College of Life Sciences at Henan Normal University, where he leads critical research in lung injury, pulmonary fibrosis, and drug development.

His career is characterized by a fusion of academic rigor and innovation, with a particular focus on diseases that have significant public health impacts.

🔬 Contributions and Research Focus

Professor Yu’s research spans molecular biology, immunology, pulmonary disease, and translational medicine. A notable area of focus has been his exploration of thyroid hormone analogs, especially GC-1, for the treatment of acute lung injury and pulmonary fibrosis. His findings have significantly contributed to the non-steroidal therapeutic approach to lung repair.

Some of his groundbreaking work includes:

  • The TRβ/KLF2/CEBPA axis, which enhances alveolar repair by guiding alveolar type 2 to type 1 cell differentiation.

  • The inhibition of macrophage inflammasomes to control cytokine storms and lung injury.

  • The identification of MMP19 from endothelial cells as a critical contributor to pulmonary fibrosis.

His work integrates molecular mechanisms with clinical application and has been published in top-tier journals such as Nature Communications, Advanced Science, Theranostics, and Cell Communication and Signaling.

🏅 Accolades and Recognition

Dr. Yu’s research excellence has earned him national and provincial funding awards from:

  • National Key Research and Development Program (2020–2023) – ¥2.85 million

  • Zhongyuan Foreign Expert Program (2020–2021) – ¥220,000

  • Henan Major Scientific and Technological Projects (2024–2026) – ¥2 million

He is recognized as a leading talent in Henan Province, and has been entrusted with managing high-impact biomedical research projects. His leadership roles in academic and governmental collaborations underscore his credibility as a national research leader.

🌍 Impact and Influence

Dr. Yu’s influence transcends borders. His international collaborations, particularly with institutions in the United States such as Yale and Pittsburgh, have facilitated the global exchange of knowledge. His work on post-COVID-19 lung pathology, innovative drug discovery, and inflammation control strategies have directly impacted public health strategies and pharmaceutical development in China.

With over 1,300 citations and increasing global interest in his work, Dr. Yu is regarded as an authority in pulmonary disease mechanisms, especially within the translational research community.

🌱 Legacy and Future Contributions

Professor Guoying Yu’s legacy lies in his ability to bridge scientific innovation with practical application. As a mentor, he continues to shape the next generation of scientists at Henan Normal University. As a scientific leader, his vision for the future includes:

  • Developing affordable therapies for lung diseases in low- and middle-income countries.

  • Enhancing China’s biomedical innovation pipeline through international cooperation.

  • Advancing precision medicine approaches tailored to complex respiratory conditions.

His ongoing work positions him not only as a trailblazer in translational lung biology but also as a guiding force for future biomedical innovation in Asia and beyond.

Publication Top Notes

Integrative analysis of gene expression and chromatin dynamics multi-omics data in mouse models of bleomycin-induced lung fibrosis

Author: Z., Li, Zhongzheng, M., Zhang, Mengke, Y., Zhang, Yujie, … G., Yu, Guoying, L., Wang, Lan

Journal: Epigenetics and Chromatin

Year: 2025

Fatty acid synthase inhibition alleviates lung fibrosis via β-catenin signal in fibroblasts

Author: H., Lian, Hui, Y., Zhang, Yujie, Z., Zhu, Zhao, … L., Wang, Lan, G., Yu, Guoying

Journal: Life Science Alliance

Year: 2025

TRβ activation confers AT2-to-AT1 cell differentiation and anti-fibrosis during lung repair via KLF2 and CEBPA

Author: X., Pan, Xin, L., Wang, Lan, J., Yang, Juntang, … I.O., Rosas, Ivan O., G., Yu, Guoying

Journal: Nature Communications

Year: 2024